Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.Chemicals Gains 2%; BSE HEALTHCARE Index Down 0.0%
Tue, 2 Jul 9:35

J.B.Chemicals Gains 2%; BSE HEALTHCARE Index Down 0.0%Image source: StarLineArts/www.istockphoto.com

J.B.Chemicals share price has zoomed 2% and is presently trading at Rs 1,827.3.

Meanwhile, the BSE HEALTHCARE index is at 37,240.5 .

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 2.2%) and HIKAL CHEMIC (up 1.4%).

MAX HEALTHCARE INSTITUTE (down 2.5%) and METROPOLIS HEALTHCARE (down 1.1%) are among the top losers today.

Over the last one year, J.B.Chemicals has moved up from Rs 1,173.7 to Rs 1,827.3, registering a gain of Rs 653.6 (up 55.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,634.3 to 37,240.5, registering a gain of 45.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 86.6%), Cadila Healthcare (up 83.5%) and Jubilant Pharmova (up 83.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,569.2 (up 0.1%).

The top gainers among the BSE Sensex today are Infosys (up 1.1%) and HCl Tech. (up 1.1%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,144.9 . ONGC and Wipro are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,915.4 to 79,569.2, registering a gain of 15,653.7 points (up 24.5%).

J.B.Chemicals Financial Update...

J.B.Chemicals net profit grew 44.0% YoY to Rs 1,262 million for the quarter ended March 2024, compared to a profit of Rs 876 million a year ago. Net sales rose 13.0% to Rs 8,617 million during the period as against Rs 7,623 million in January-March 2023.

For the year ended March 2023, J.B.Chemicals reported 6.2% increase in net profit to Rs 4,100 million compared to net profit of Rs 3,860 million during FY22. Revenue of the company grew 29.9% to Rs 31,493 million during FY23.

The current Price to earnings ratio of J.B.Chemicals, based on rolling 12 month earnings, stands at 51.3.


Equitymaster requests your view! Post a comment on "J.B.Chemicals Gains 2%; BSE HEALTHCARE Index Down 0.0%". Click here!